Featured
-
-
Article
| Open AccessA novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models
- Urara Tomita
- , Yoko Ishimoto
- & Toshinori Agatsuma
-
Article
| Open AccessPopulation pharmacokinetics of lenalidomide in Chinese patients with influence of genetic polymorphisms of ABCB1
- Xiaoxiao Liang
- , Haiyan Shi
- & Xin Huang
-
Article
| Open AccessAssociation of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials
- Sara A. Almansour
- , Mohammad A. Y. Alqudah
- & Ahmad Y. Abuhelwa
-
Article
| Open AccessA population-based study on incidence trends of myeloma in the United States over 2000–2020
- Seyed Ehsan Mousavi
- , Mehran Ilaghi
- & Seyed Aria Nejadghaderi
-
Article
| Open AccessCancer-associated fibroblast-derived exosome microRNA-21 promotes angiogenesis in multiple myeloma
- Sun Miaomiao
- , Wang Xiaoqian
- & Chen Kuisheng
-
Article
| Open AccessIL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma
- Cong Xu
- , Meng Gao
- & Yunfeng Fu
-
Article
| Open AccessIncidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea
- Da Jung Kim
- , Seri Jeong
- & Ho Sup Lee
-
Article
| Open AccessPrognostic prediction of novel risk scores (AML-DRG and AML-HCT-CR) in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation
- Weijie Cao
- , Xiaoning Li
- & Jifeng Yu
-
Article
| Open AccessTumor immune cell infiltration score based model predicts prognosis in multiple myeloma
- Can Chen
- , Yiwei Li
- & Shenxian Qian
-
Article
| Open AccessCalorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma
- Alanah L. Bradey
- , Stephen Fitter
- & Andrew C. W. Zannettino
-
Article
| Open AccessExploiting gene dependency to inform drug development for multiple myeloma
- Molly Went
- , Phuc H. Hoang
- & Richard S. Houlston
-
Article
| Open AccessPaired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma
- Kristin Roseth Aass
- , Tonje Marie Vikene Nedal
- & Robin Mjelle
-
Article
| Open AccessThe metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome
- Silja Richter
- , Martin Böttcher
- & Dimitrios Mougiakakos
-
Article
| Open AccessQuantitative systems pharmacology modeling sheds light into the dose response relationship of a trispecific T cell engager in multiple myeloma
- R. E. Abrams
- , K. Pierre
- & S. K. Stamatelos
-
Article
| Open AccessPonatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model
- Evan Flietner
- , Zhi Wen
- & Jing Zhang
-
Article
| Open AccessBaseline peripheral neuropathy was associated with age and a prognostic factor in newly diagnosed multiple myeloma patients
- Mengmeng Dong
- , Jinna Zhang
- & Zhen Cai
-
Article
| Open AccessCytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
- Jihye Ha
- , Hyunsoo Cho
- & Jong Rak Choi
-
Article
| Open AccessSupporting the gastrointestinal microenvironment during high-dose chemotherapy and stem cell transplantation by inhibiting IL-1 signaling with anakinra
- H. R. Wardill
- , C. E. M. de Mooij
- & N. M. A. Blijlevens
-
Article
| Open Access11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma
- Miao Chen
- , Wenjia Zhu
- & Junling Zhuang
-
Article
| Open AccessQuantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
- Kentaro Narita
- , Daisuke Miura
- & Kosei Matsue
-
Article
| Open AccessNext generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients
- Ciara Tierney
- , Despina Bazou
- & Peter O’Gorman
-
Article
| Open AccessThe influence of high-efficiency particulate air filtration on mortality among multiple myeloma patients receiving autologous stem cell transplantation
- Chun-Kuang Tsai
- , Chiu-Mei Yeh
- & Chia-Jen Liu
-
Article
| Open AccessComparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
- Takeshi Yoroidaka
- , Kentaro Narita
- & Kosei Matsue
-
Article
| Open AccessA proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma
- Kwan Yeung Wong
- , Gareth J. Morgan
- & Chor Sang Chim
-
Article
| Open AccessThe combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells
- Yurie Nagai
- , Naoya Mimura
- & Emiko Sakaida
-
Article
| Open AccessQuantitative and functional characteristics of circulating and bone marrow PD-1- and TIM-3-positive T cells in treated multiple myeloma patients
- Egor V. Batorov
- , Tatiana A. Aristova
- & Elena R. Chernykh
-
Article
| Open AccessMultiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment
- Lanting Liu
- , Zhen Yu
- & Mu Hao
-
Article
| Open AccessTargeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models
- Viktoria Kunz
- , Kathryn S. Bommert
- & Kurt Bommert
-
Article
| Open AccessOsteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23
- Patrick L. Mulcrone
- , Shanique K. E. Edwards
- & G. David Roodman
-
Article
| Open AccessFemale sex as an independent prognostic factor in the development of oral mucositis during autologous peripheral stem cell transplantation
- Enikő Gebri
- , Attila Kiss
- & Tibor Hortobágyi
-
Article
| Open AccessPD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis: developing a nomogram-based prognostic model
- Byung-Hyun Lee
- , Yong Park
- & Byung Soo Kim
-
Article
| Open AccessMetabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma
- Wilson I. Gonsalves
- , Katarzyna Broniowska
- & Shaji K. Kumar
-
Article
| Open AccessConcepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
- Mehmet Baysal
- , Ufuk Demirci
- & Ahmet Muzaffer Demir
-
Article
| Open AccessHigh-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling
- A. Romano
- , N. L. Parrinello
- & F. Di Raimondo
-
Article
| Open AccessA higher throughput assay for quantification of melphalan-induced DNA damage in peripheral blood mononuclear cells
- Maia van Kan
- , Kathryn E. Burns
- & Nuala A. Helsby
-
Article
| Open AccessDPP8 is a novel therapeutic target for multiple myeloma
- Tsutomu Sato
- , Ayumi Tatekoshi
- & Chikao Morimoto
-
Article
| Open AccessAssessment of TP53 lesions for p53 system functionality and drug resistance in multiple myeloma using an isogenic cell line model
- Umair Munawar
- , Markus Roth
- & Thorsten Stühmer
-
Article
| Open AccessThe Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia
- Ling Cao
- , Weilong Zhang
- & Xiaoliang Yuan
-
Article
| Open AccessMicrobial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients
- Alexa M. G. A. Laheij
- , Judith E. Raber-Durlacher
- & Egija Zaura
-
Article
| Open AccessDistinctive patterns of peripheral neuropathy across the spectrum of plasma cell disorders
- Ja Min Byun
- , Young Nam Kwon
- & Inho Kim
-
Article
| Open AccessCereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
- Phoebe A. Huang
- , Shaunna L. Beedie
- & William D. Figg
-
Article
| Open AccessMultiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone microenvironment
- Sam W. Z. Olechnowicz
- , Megan M. Weivoda
- & Claire M. Edwards
-
Article
| Open AccessRapid discrimination of multiple myeloma patients by artificial neural networks coupled with mass spectrometry of peripheral blood plasma
- Meritxell Deulofeu
- , Lenka Kolářová
- & Petr Vaňhara
-
Article
| Open AccessEndogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells
- Hiroyuki Yamazaki
- , Kotaro Shirakawa
- & Akifumi Takaori-Kondo
-
Article
| Open AccessH727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth
- Min Jae Lee
- , Zachary Miller
- & Kyung Bo Kim
-
Article
| Open AccessIn Vivo Flow Cytometry of Extremely Rare Circulating Cells
- Xuefei Tan
- , Roshani Patil
- & Mark Niedre
-
Article
| Open AccessToll-Like Receptor 4 Activation Promotes Multiple Myeloma Cell Growth and Survival Via Suppression of The Endoplasmic Reticulum Stress Factor Chop
- Tina Bagratuni
- , Aimilia D. Sklirou
- & Meletios A. Dimopoulos
-
Article
| Open AccessStandardized assay for assessment of minimal residual disease in blood, bone marrow and apheresis from patients with plasma cell myeloma
- Agnieszka Blum
- , Katy Haussmann
- & Lutz Uharek
-
Article
| Open AccessThe genetic landscape of 5T models for multiple myeloma
- Ken Maes
- , Bram Boeckx
- & Elke De Bruyne